Atlas Trials

Clinical Validation of ColonAiQ (a Blood-based Assay Targeting ctDNA Methylation) for Colorectal Cancer Detection

Clinical trial NCT06347887 · COMPLETED

Trial details

NCT number
NCT06347887
Sponsor
Singlera Genomics Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Colorectal Cancer
Start date
2021-05-31
Primary completion
2024-01-16
Enrollment
1965

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.